Ignalis MP 500 Tablet SR
Ignalis MP 500 Tablet SR
Metformin (500mg) + Pioglitazone (15mg) + Sitagliptin (100mg)
Glura MP 500 Tablet SR
Eris Lifesciences Ltd
Pioglitazone 15mg
Pack Size
1 units
Price
Save ₹0
that's 0% off!
About This Medicine
Product description & overview
Ignalis MP 500 Tablet SR: A Combination Treatment for Type 2 Diabetes
Ignalis MP 500 Tablet SR is a once-daily combination therapy designed to manage blood sugar levels in adults with Type 2 Diabetes. This extended-release tablet contains Metformin (500mg), Pioglitazone (15mg), and Sitagliptin (100mg). These three active ingredients work synergistically to:
* Improve insulin sensitivity: Metformin enhances insulin activity, reducing blood sugar levels.
* Decrease hepatic glucose production: Pioglitazone reduces the liver's contribution to increased blood sugar.
* Potentiate pancreatic function: Sitagliptin inhibits the enzyme responsible for producing certain enzymes in the pancreas that contribute to high blood sugar.
Ignalis MP 500 Tablet SR helps manage Type 2 Diabetes effectively and improve glycemic control, promoting a healthier lifestyle for patients.
Note: This description is for informational purposes only and does not substitute professional medical advice. Consult with a healthcare provider before starting or discontinuing any medication.
Active composition
Metformin 500 mg
+2 more active ingredients
About Metformin
Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Sitagliptin
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Pioglitazone
Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-γ), enhancing insulin sensitivity and glucose metabolism.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Information regarding the use of Ignalis MP 500 Tablet SR during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Ignalis MP 500 Tablet SR during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
There is limited information available on the use of Ignalis MP 500 Tablet SR in patients with kidney disease. Please consult your doctor.
Exercise Caution
Breastfeeding
It is not known whether Ignalis MP 500 Tablet SR alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Kidney
There is limited information available on the use of Ignalis MP 500 Tablet SR in patients with liver disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Ignalis MP 500 Tablet SR